Spanish Court Deals Blow To Merck In Zocor Patent Suit

Law360, New York (April 19, 2004, 12:00 AM EDT) -- A Spanish court has ruled in favor of a unit of Bentley Pharmaceuticals, dealing Merck & Co. another blow in its attempt to protect its anti-cholesterol blockbuster drug Zocor from generic protection in Spain.

Earlier this month, the court ruled in favor of Laboratorios Belmac, Bentley’s Spanish subsidiary in Merck’s patent lawsuit against the company, ordering Merck to pay all of Laboratorios Belmac's legal costs without limitation.

Zocor is the world's second-largest selling drug, behind Lipitor, with $6.1 billion in sales. The U.S. patent on Zocor...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.